TrialThe Journal of clinical investigation2017

Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia.

Lothar Seefried et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.